EHR

PDR expands its services beyond the book

PDR expands its services beyond the book

By

Physicians Desk Reference is on a mission to expand its image beyond just being that heavy book doctors consult for information

CMS lax in EHR-enabled fraud, OIG says

CMS lax in EHR-enabled fraud, OIG says

By

CMS could provide more guidance for how to crack down on healthcare fraud, the OIG asserts in a report.

E-prescribing systems not so pharma friendly

E-prescribing systems not so pharma friendly

By

A study points out barriers to e-prescribing pharma products and shows how doctors rate various EHRs.

Pharma eyes EHR for engaging with docs

Pharma eyes EHR for engaging with docs

By

EHRs could be a vehicle for pharma to find its way into the physician's workflow. First, industry needs to learn how to leverage them appropriately.

NY'ers to get first taste of Big Data, as creation of state's patient portal gets under way

NY'ers to get first taste of Big Data, as creation of state's patient portal gets under way

By

The state's first patient portal has officially entered development, and the e-health firm leading the effort said that a former WebMD executive joined its board.

Epocrates scooped up for $293M

Epocrates scooped up for $293M

By

The company is being purchased by medical cloud networker Athenahealth.

MPR gets new look, adds e-prescriptions

By

Monthly Prescribing Reference's first revamp in three years includes new features which have already attracted new users. VP of product development Tammy Chernin told MM&M these changes are just the beginning.

Pri-Med in deal to buy EHR firm

By

The med-ed company is buying Amazing Charts, a tie-up the firms say will enable them to deliver customized education to physicians and then assess the patient-level impact.

Company news: GlaxoSmithKline, DIA and PDR Network

The DIA and the Healthcare Businesswomen's Association formalized a multi-year partnership, and GSK began shipping vaccine for the 2012-2013 flu season

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.